{"nctId":"NCT00409409","briefTitle":"Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis","startDateStruct":{"date":"2006-12"},"conditions":["Allergy"],"count":278,"armGroups":[{"label":"300 IR","type":"EXPERIMENTAL","interventionNames":["Drug: 300 IR grass pollen allergen extract tablet"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo tablet"]}],"interventions":[{"name":"300 IR grass pollen allergen extract tablet","otherNames":["Sublingual immunotherapy tablet"]},{"name":"Placebo tablet","otherNames":["Sublingual placebo tablet"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female outpatients aged 5 to 17 years.\n* Written consent / assent.\n* Grass pollen-related allergic rhinoconjunctivitis for at least the last two pollen seasons.\n* Sensitised to grass pollen (positive SPT and grass pollen-specific IgE values of at least Class 2).\n* Total symptom score on the Retrospective RTSS during the previous pollen season of greater than or equal to 12.\n\nExclusion Criteria:\n\n* Patients who have received any desensitisation treatment for grass pollen.","healthyVolunteers":false,"sex":"ALL","minimumAge":"5 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Average Rhinoconjunctivitis Total Symptom Score (ARTSS)","description":"Average Rhinoconjunctivitis Total Symptom Score during the pollen period while participant on treatment.\n\nParticipants assessed daily, during the pollen period, 6 rhinoconjunctivitis symptoms (sneezing, rhinorrhea, nasal pruritus, nasal congestion, ocular pruritus and watery eyes) each symptom is scored as follows: 0: no symptoms, 1: mild symptoms, 2: moderate symptoms, 3: severe symptoms. The sum of the 6 symptoms is the Rhinoconjunctivitis Total Symptom Score (RTSS) (range 0-18). The lower the score, the better the outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.25","spread":"2.860"},{"groupId":"OG001","value":"4.51","spread":"2.931"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":139},"commonTop":["COUGH","ORAL PRURITUS","NASOPHARYNGITIS","HEADACHE","SNEEZING"]}}}